Skip to main content
Fig. 1 | Cardio-Oncology

Fig. 1

From: Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis

Fig. 1

Changes in cardiac biomarker levels at Pre-Chemo, End-Chemo, and Post-Chemo. (a) 5th generation high-sensitivity cardiac troponin T (cTnT), (b) N-terminal pro-brain natriuretic peptide (NT-proBNP), (c) growth/differentiation factor-15 (GDF-15), and (d) soluble suppression of tumorigenesis-2 (sST2) biomarker levels at three time points: prior to chemotherapy (Pre-Chemo), after the last dose of doxorubicin (End-Chemo), and 3-6 months after completion of doxorubicin (Post-Chemo). *** p < 0.001, ** p  < 0.01, * p < 0.05

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us